Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IS-CRITIC: Inhaled Sedation in Critically Ill Patients
NCT07000526Phase 4Recruiting
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of isoflurane in critical illness, sponsored by Hospital La Paz Institute for Health Research. Started Dec 2025; status: recruiting.
02
Drugs
isoflurane
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT07000526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07000526.